VANI vs. FONR, HYPR, MOVE, ECOR, ELMD, PXDT, POCI, OM, SMLR, and AXGN
Should you be buying Vivani Medical stock or one of its competitors? The main competitors of Vivani Medical include FONAR (FONR), Hyperfine (HYPR), Movano (MOVE), electroCore (ECOR), Electromed (ELMD), Pixie Dust Technologies (PXDT), Precision Optics (POCI), Outset Medical (OM), Semler Scientific (SMLR), and AxoGen (AXGN). These companies are all part of the "electromedical equipment" industry.
Vivani Medical (NASDAQ:VANI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.
FONAR received 168 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 73.48% of users gave FONAR an outperform vote.
FONAR has a net margin of 12.63% compared to Vivani Medical's net margin of 0.00%. FONAR's return on equity of 8.47% beat Vivani Medical's return on equity.
FONAR has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 50.6% of FONAR shares are owned by institutional investors. 55.6% of Vivani Medical shares are owned by insiders. Comparatively, 2.2% of FONAR shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Vivani Medical had 5 more articles in the media than FONAR. MarketBeat recorded 7 mentions for Vivani Medical and 2 mentions for FONAR. Vivani Medical's average media sentiment score of 0.31 beat FONAR's score of 0.30 indicating that Vivani Medical is being referred to more favorably in the media.
Vivani Medical has a beta of 3.26, indicating that its stock price is 226% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.
Summary
FONAR beats Vivani Medical on 9 of the 14 factors compared between the two stocks.
Get Vivani Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vivani Medical Competitors List
Related Companies and Tools
